WASHINGTON--(BUSINESS WIRE)--Aug 13, 2010 - Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.
